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BSTRACT
 
Background
 
Radial scars are benign breast le-
sions of uncertain clinical significance. In particular,
it is not known whether these lesions alter the risk of
breast cancer in women with benign breast disease.
We conducted a case–control study of women who
had benign breast lesions with or without radial scars.
 
Methods
 
We reviewed benign breast-biopsy spec-
imens from 1396 women enrolled in the Nurses’
Health Study, including 255 women in whom breast
cancer subsequently developed and 1141 women
without subsequent breast cancer (controls). The con-
trols were matched to the women with subsequent
breast cancer according to age and the year when
the benign lesion was identified. The median follow-
up after biopsy of the benign lesions was 12 years.
 
Results
 
Radial scars were identified in biopsy
specimens from 99 women (7.1 percent). Most biop-
sy specimens with radial scars had only one radial
scar (60.6 percent), and they tended to be incidental
microscopical findings (median size, 4.0 mm). The
women with radial scars had a risk of breast cancer
that was almost twice the risk of the women without
scars, regardless of the histologic type of benign
breast disease (relative risk, 1.8; 95 percent confi-
dence interval, 1.1 to 2.9). Among women who had
proliferative disease without atypia as compared with
women who had nonproliferative disease, the rela-
tive risk of breast cancer was 3.0 (95 percent confi-
dence interval, 1.7 to 5.5) for those with radial scars
and 1.5 (95 percent confidence interval, 1.1 to 2.1) for
those without radial scars. Among women with atyp-
ical hyperplasia as compared with women with non-
proliferative disease, the relative risk of breast can-
cer was 5.8 (95 percent confidence interval, 2.7 to
12.7) for those with radial scars and 3.8 (95 percent
confidence interval, 2.4 to 5.9) for those without ra-
dial scars.
 
Conclusions
 
Radial scars are an independent his-
tologic risk factor for breast cancer. (N Engl J Med
1999;340:430-6.)
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LINICAL studies have shown that among
women with benign breast disease on bi-
opsy, the risk of subsequent breast cancer
is associated with the histologic category
of the benign disease.
 
1-3
 
 In particular, the risk of
breast cancer among women with benign prolifera-
tive lesions without atypia is almost twice the risk
among women with nonproliferative disease, where-
as the risk among those with atypical hyperplasia is
four to five times the risk among those with nonpro-
liferative disease. Other studies have refined the risk
estimates by evaluating the risk of breast cancer as-
sociated with different types of atypical hyperplasia
 
4
 
or specific benign lesions such as sclerosing adeno-
sis,
 
5
 
 fibroadenomas,
 
6
 
 and papillomas.
 
7
 
Radial scars are a specific type of benign breast le-
sion that pathologists commonly detect, yet the risk
of subsequent breast cancer associated with these le-
sions is unknown. Furthermore, it is not known
whether the presence of radial scars in women with
different histologic categories of benign breast dis-
ease alters the risk of breast cancer.
Radial scars are characterized microscopically by a
fibroelastotic core from which ducts and lobules ra-
diate. These ducts and lobules exhibit various alter-
ations, including cysts and proliferative lesions (Fig.
1). Radial scars are most often incidental microscop-
ical findings in breast tissue removed because of oth-
er possible abnormalities. However, larger radial scars
are being detected with increasing frequency in wom-
en who undergo mammographic screening. The mor-
phologic similarity of radial scars to cancer
 
8-12
 
 and
the finding of carcinoma in some radial scars
 
13-15
 
 have
suggested that these lesions may represent an early
phase in the development of certain types of breast
cancer. Several studies have evaluated the frequency
of radial scars in women with breast cancer, but with
conflicting results.
 
16-19
 
 The few clinical follow-up stud-
ies that have been performed have not demonstrated
an increased risk of cancer among women with radi-
al scars, but these studies were small and lacked suit-
able controls.
 
20,21
 
To examine the association between the presence
C
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of radial scars and the subsequent risk of breast can-
cer in women with various categories of benign breast
disease, we conducted a case–control study within
the Nurses’ Health Study, which is a long-term, pro-
spective study of risk factors for breast carcinoma in
women in the United States.
 
METHODS
 
Study Population
 
The first Nurses’ Health Study began in 1976, when 121,701
female registered nurses born between 1921 and 1946 responded
to a mailed questionnaire about potential risk factors for breast
cancer and medical history. The second Nurses’ Health Study be-
gan in 1989, when 116,671 female registered nurses born be-
tween 1946 and 1964 responded to a similar mailed question-
naire. Every two years, participants in both studies complete a
questionnaire that updates this information. On all question-
naires, participants are asked about a past diagnosis of benign
breast disease requiring hospitalization or confirmed by a breast
biopsy.
Eligible participants in the current study included all women in
the Nurses’ Health Study who had not received a diagnosis of
cancer (other than nonmelanoma skin cancer) at the beginning
of each two-year follow-up interval and who reported a diagnosis
of benign breast disease with either hospitalization or biopsy on
the initial questionnaire or a subsequent questionnaire. Among
these participants, any woman who reported a diagnosis of breast
cancer (except lobular carcinoma in situ) at least one year after
the first reported diagnosis of benign breast disease and before
July 1992 (for participants in the first Nurses’ Health Study) or
July 1991 (for those in the second) was considered to have breast
cancer. For each of the women with breast cancer, up to four con-
trols without cancer were randomly selected from the women
who were born the same year and who received the diagnosis of
benign disease the same year.
All eligible participants were asked to provide written consent
to allow retrieval and review of the pathology slides from the first
biopsy showing benign breast disease. Seventy percent of the re-
spondents confirmed a prior diagnosis of benign disease and pro-
vided permission to obtain the slides; the other 30 percent did
not provide permission or had died shortly after the diagnosis of
breast cancer. We were able to obtain slides for 49 percent of the
women who provided consent. Slides were not available for the
other 51 percent because the hospital no longer existed, the slides
had not been kept, or the policy of the pathology department was
not to release pathological material of any kind. Although the
overall rate of success in obtaining slides was low (34 percent),
the rate did not differ significantly between women who had a
subsequent diagnosis of breast cancer and those who did not. For
16 of the participants, the submitted slides contained no breast
tissue, and these women were excluded from subsequent analyses.
Reports on earlier stages of this ongoing, nested case–control
study provide detailed descriptions of case ascertainment and re-
view of biopsy specimens from 1976 through 1988.
 
2,4
 
 For the
present analysis, we reviewed biopsy specimens from 1396 women.
 
Histologic Examination
 
Each biopsy specimen was initially evaluated by one of us with-
out knowledge of whether breast cancer subsequently developed.
Included in these analyses were 255 women with subsequent
breast cancer and 1141 controls whose slides had been reviewed
before March 1997. For the purpose of this analysis, breast cancer
was defined as invasive carcinoma or ductal carcinoma in situ. For
women with bilateral biopsies that confirmed the presence of be-
nign disease in both breasts, the side with the more pronounced
histologic abnormalities was used for the purpose of histologic
classification. If the two sides showed equally pronounced abnor-
malities, one was selected randomly.
The benign lesions were initially classified as nonproliferative
lesions, proliferative lesions without atypia, or atypical hyperpla-
sia, according to the criteria of Dupont and Page et al.
 
1,22
 
 Non-
proliferative lesions included unremarkable breast tissue, cysts,
ductal ectasia, apocrine metaplasia, and mild ductal hyperplasia;
proliferative lesions without atypia included radial scars, intraduc-
tal papillomas, sclerosing adenosis, fibroadenomas, and moderate-
to-florid ductal hyperplasia; and atypical hyperplasia included
ductal and lobular types.
 
1,22
 
 In keeping with the evidence that
women with fibroadenomas have a higher risk of breast cancer
than women without these lesions,
 
6
 
 fibroadenomas and fibroade-
nomatous changes were classified as proliferative lesions without
atypia. Biopsy specimens showing possible or definite atypical hy-
perplasia were subsequently reviewed jointly by two of us, and a
consensus on the classification was obtained.
A total of 103 women who were considered to have radial scars
according to the initial review had slides available for reexamina-
tion. Biopsy specimens with equivocal features of radial scars and
those with radial scars that showed possible or definite atypia
were subsequently reviewed by three of us, and a consensus was
obtained. On this subsequent review, radial scars were not iden-
tified in four women, and these findings were recoded appropri-
ately. The following additional features were recorded for the bi-
 
Figure 1.
 
 Histologic Features of a Radial Scar.
A low-power view shows the fibroelastotic core, with radiating
ducts and lobules exhibiting proliferative changes and micro-
cysts (Panel A, ¬20). A high-power view of the central fibro-
elastotic area shows entrapped benign ducts (Panel B, ¬400).
 
A
B
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opsy specimens from the 99 women found to have radial scars on
the second review: the number of radial scars and their size and
the presence or absence of atypical hyperplasia (ductal or lobular)
within the radial scars.
 
Statistical Analysis
 
To determine the relative risk of breast cancer associated with
radial scars in women with various types of benign breast disease,
we performed logistic-regression analyses adjusted for age, the
year of the biopsy showing benign breast disease, and other po-
tential confounding factors in order to obtain maximum-likeli-
hood estimates and 95 percent confidence intervals, using the
SAS software package.
 
23,24
 
 Chi-square analyses were conducted to
compare the proportions of women with breast cancer and con-
trols who had radial scars, according to the number and size of
the scars.
 
25
 
Data on covariates were obtained from the biennial question-
naires completed by the study participants from the time of the
diagnosis of benign breast disease until the follow-up interval
during which breast cancer was diagnosed. In this way, data on
covariates were updated as appropriate.
We first examined the prevalence of risk factors for breast can-
cer among women with and those without radial scars to deter-
mine whether there were confounding factors. In keeping with
accepted epidemiologic practice, we identified confounding fac-
tors on the basis of the magnitude of the association rather than
on the basis of statistical significance. The covariates included in
the analyses were age at menarche (less than 12, 12, 13, or 14 or
more years), presence or absence of a history of breast cancer in
first-degree relatives, body-mass index (categorized according to
the quartile distribution in controls), menopausal status (pre-
menopausal, postmenopausal, or uncertain), and parity and age
at birth of first child (nulliparous, parous with first birth before
the age of 25 years, parous with first birth between the ages of
25 and 29, and parous with first birth at the age of 30 or older).
In all models, women with breast cancer and controls were
matched for age at the time of the diagnosis of breast cancer, the
year of the diagnosis of benign breast disease, and the follow-up
interval.
 
RESULTS
 
Among the 1396 women with benign breast dis-
ease whose biopsy specimens we reviewed, radial
scars were identified in 99 (7.1 percent). The rela-
tion between radial scars and other risk factors for
breast cancer is shown in Table 1. Women with radial
scars were older and more likely to be postmeno-
pausal than those without radial scars, and women
with radial scars and subsequent breast cancer were
more likely to have a family history of breast cancer.
There was no relation between the presence of a ra-
dial scar and age at menarche, parity, age at birth of
first child, or body-mass index.
 
*Numbers may not sum to total numbers, because of missing data for some covariates. In addition,
not all covariates are shown.
†For the women with subsequent breast cancer, age was recorded as the age at the time of the
diagnosis of cancer; all other covariate information was obtained from the questionnaire preceding
the diagnosis. For the matched controls, age was recorded as the age at the end of the corresponding
follow-up interval; all other covariate information was obtained from the questionnaire preceding the
end of the relevant follow-up interval.
‡The body-mass index was calculated as the weight in kilograms divided by the square of the height
in meters.
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N
 
=67)
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WITH
SUBSEQUENT
BREAST
 
 
 
CANCER
 
(
 
N
 
=223)
 
CONTROLS
 
(
 
N
 
=1074)
 
no. of women (%)
 
Age 
<45 yr
45–54 yr
»55 yr
1 (3.1)
11 (34.4)
20 (62.5)
3 (4.5)
21 (31.3)
43 (64.2)
32 (14.3)
102 (45.7)
89 (39.9)
142 (13.2)
472 (43.9)
460 (42.8)
Age at menarche
<13 yr
»13 yr
15 (46.9)
17 (53.1)
31 (46.3)
35 (52.2)
105 (47.1)
115 (51.6)
481 (44.8)
588 (54.7)
Parity and age at first birth
Nulliparous
Parous
<25 yr at first birth
25–29 yr at first birth
»30 yr at first birth
1 (3.1)
12 (37.5)
17 (53.1)
1 (3.1)
4 (6.0)
32 (47.8)
26 (38.8)
5 (7.5)
18 (8.1)
99 (44.4)
75 (33.6)
28 (12.6)
76 (7.1)
543 (50.6)
343 (31.9)
95 (8.8)
Family history of breast cancer 11 (34.4) 9 (13.4) 33 (14.8) 131 (12.2)
Menopausal status
Premenopausal
Postmenopausal
8 (25.0)
24 (75.0)
16 (23.9)
46 (68.7)
90 (40.4)
109 (48.9)
410 (38.2)
544 (50.7)
Body-mass index‡
<25
»25
22 (68.8)
10 (31.2)
44 (65.7)
23 (34.3)
163 (73.1)
60 (26.9)
695 (64.7)
376 (35.0)
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Most radial scars were incidental microscopical
findings, with an overall median size of 4.0 mm
(range, 1.5 to 13.5) (Table 2). The mean size of the
radial scars was similar in the women with subse-
quent diagnoses of breast cancer and the controls
(mean sizes, 4.7 mm and 4.4 mm, respectively; P=
0.58). A single radial scar was present in biopsy
specimens from 60.6 percent of the women, two ra-
dial scars were present in specimens from 21.2 per-
cent, and three or more scars were present in the re-
mainder of the biopsy specimens. The number of
radial scars per biopsy specimen was similar for wom-
en with subsequent breast cancer and controls. Atyp-
ical hyperplasia was identified within radial scars in
biopsy specimens from eight women (six with atyp-
ical ductal hyperplasia and two with atypical lobular
hyperplasia), with equal numbers among the women
with subsequent cancer and the controls (Table 2).
The benign lesions were classified as nonprolifer-
ative disease in 65 women with subsequent breast
cancer (25.5 percent) and in 453 controls (39.7 per-
cent), proliferative disease without atypia in 129
women with subsequent breast cancer (50.6 per-
cent) and 570 controls (50.0 percent), and atypical
hyperplasia in 61 women with subsequent breast
cancer (23.9 percent) and 118 controls (10.3 per-
cent) (Table 3). Radial scars were present in 12.5
percent of the women with subsequent breast cancer
and 5.9 percent of the controls.
Overall, the presence of a radial scar was associat-
ed with almost a doubling of the risk of breast can-
cer, regardless of the histologic category of benign
breast disease (relative risk for women with radial
scars as compared with those without radial scars,
1.8; 95 percent confidence interval, 1.1 to 2.9).
When the analysis was adjusted for the presence of
a radial scar, the relative risk of breast cancer was 1.5
(95 percent confidence interval, 1.1 to 2.1) for wom-
en who had proliferative disease without atypia and
3.6 (95 percent confidence interval, 2.4 to 5.6) for
those with atypical hyperplasia, in comparison with
women who had nonproliferative disease. 
The presence of a radial scar further increased the
 
*Percentages may not sum to 100, because of rounding.
†For women with more than one radial scar, the largest scar was used
for the analysis of size.
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(N=32)
C
 
ONTROLS
 
(N=67)
 
Size of radial scar — mm†
Mean
Median
Range
4.5
4.0
1.5–13.5
4.7
4.0
1.5–9.5
4.4
4.0
1.5–13.5
No. of radial scars — 
no. of women (%)
1 
2 
3 
4 
»5 
60 (60.6)
21 (21.2)
4 (4.0)
8 (8.1)
6 (6.1)
15 (46.9)
8 (25.0)
2 (6.2)
5 (15.6)
2 (6.2)
45 (67.2)
13 (19.4)
2 (3.0)
3 (4.5)
4 (6.0)
Radial scars with atypical hyper-
plasia — no. of women (%)
Ductal
Lobular
8 (8.1)
6
2
4 (12.5)
3
1
4 (6.0)
3
1
*These relative risks were adjusted for age, year of biopsy, and follow-up interval. CI denotes con-
fidence interval.
†These relative risks were further adjusted for age at menarche (<12, 12, 13, or »14 years), family
history of breast cancer (yes or no), body-mass index (in quintiles), menopausal status, and parity
and age at birth of first child (nulliparous; parous, <25 years; parous, 25 to 29 years; or parous, »30
years). CI denotes confidence interval.
‡Nonproliferative disease was the reference category.
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R
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 R
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(95% CI)†
 
no. of women
 
Nonproliferative‡ 65 453 1.0 1.0
Proliferative without atypia
Without radial scars
With radial scars
110
19
521
49
1.5 (1.1–2.1)
3.0 (1.7–5.5)
1.5 (1.1–2.1)
2.7 (1.5–5.0)
Atypical hyperplasia
Without radial scars
With radial scars
48
13
100
18
3.8 (2.4–5.9)
5.8 (2.7–12.7)
3.7 (2.4–5.9)
5.3 (2.4–11.6)
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risk of breast cancer among women who had prolif-
erative disease without atypia and those who had
atypical hyperplasia, as compared with those who
had nonproliferative disease (Table 3). The relative
risk of breast cancer for women who had prolifera-
tive disease without atypia and who did not have ra-
dial scars was 1.5 (95 percent confidence interval,
1.1 to 2.1), whereas the risk for women with radial
scars and proliferative lesions without atypia was 3.0
(95 percent confidence interval, 1.7 to 5.5). Thus,
among women who had proliferative disease with-
out atypia, the risk of breast cancer was 90 percent
greater if radial scars were present than if they were
absent (relative risk, 1.9; 95 percent confidence in-
terval, 1.1 to 3.5; P=0.028). For women who had
atypical hyperplasia without radial scars, the relative
risk of breast cancer was 3.8 (95 percent confidence
interval, 2.4 to 5.9), whereas for those who had
atypical hyperplasia with radial scars, the relative risk
was 5.8 (95 percent confidence interval, 2.7 to 12.7).
Therefore, among women with atypical hyperplasia,
the presence of radial scars increased the risk of sub-
sequent breast cancer by 70 percent (relative risk,
1.7; 95 percent confidence interval, 0.7 to 4.0; P=
0.226). These relative risks were adjusted for age,
year of biopsy of benign breast lesions, and follow-
up interval. Adjustment for other known risk factors
for breast cancer, including age at menarche, family
history of breast cancer, body-mass index, menopaus-
al status, parity, and age at birth of first child, did
not substantially alter these associations (Table 3).
When the data were stratified according to the
number of radial scars per biopsy specimen, the rel-
ative risk of breast cancer among the women with
proliferative disease with or without atypia, as com-
pared with those who had nonproliferative disease,
increased with the number of radial scars. Among
the women who had proliferative disease without
atypia and more than one radial scar, the relative risk
was 4.3 (95 percent confidence interval, 1.7 to 10.8),
and among the women with atypical hyperplasia and
more than one radial scar, the relative risk was 8.4
(95 percent confidence interval, 3.1 to 22.9) (Table
4). Similarly, the relative risk of breast cancer in-
creased with the size of the radial scars. Among the
women who had proliferative disease without atypia
and who had a radial scar that was 4 mm or more in
diameter, the relative risk was 3.5 (95 percent confi-
dence interval, 1.7 to 7.3), and among those with
atypical hyperplasia and a radial scar that was 4 mm
or more in diameter, the relative risk was 8.8 (95
percent confidence interval, 3.5 to 22.0) (Table 5).
Information on the laterality of the initial benign
breast disease and subsequent breast cancer was avail-
able for 197 women. Overall, cancer developed on
the same side as the previous benign disease in 97
(49.2 percent) of these women. Of the 24 women
with radial scars, 11 (46 percent) had subsequent
cancer in the ipsilateral breast, and 13 (54 percent)
had subsequent cancer in the contralateral breast.
Of the 16 women who had proliferative disease
without atypia and who had radial scars, 8 had sub-
sequent cancer in the ipsilateral breast and 8 had
subsequent cancer in the contralateral breast. Of
the eight women with atypical hyperplasia and radi-
al scars, three had subsequent cancer in the ipsilat-
eral breast and five had subsequent cancer in the
contralateral breast. None of the women with bilat-
eral breast cancer had radial scars as part of their be-
nign breast disease.
 
*Relative risks were adjusted for age, year of biopsy, and follow-up in-
terval. CI denotes confidence interval.
†Nonproliferative disease was the reference category.
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 RISK OF BREAST CANCER ACCORDING TO
HISTOLOGIC CATEGORY OF BENIGN BREAST DISEASE 
AND NUMBER OF RADIAL SCARS.
HISTOLOGIC CATEGORY AND 
NO. OF RADIAL SCARS
WOMEN WITH
SUBSEQUENT
BREAST
CANCER CONTROLS
RELATIVE RISK
(95% CI)*
no. of women
Nonproliferative† 65 453 1.0
Proliferative without atypia
0 scars
1 scar
>1 scar
110
11
8
521
35
14
1.5 (1.1–2.1)
2.5 (1.2–5.2)
4.3 (1.7–10.8)
Atypical hyperplasia
0 scars
1 scar
>1 scar
48
4
9
100
10
8
3.8 (2.4–5.9)
3.5 (1.0–11.7)
8.4 (3.1–22.9)
*Relative risks were adjusted for age, year of biopsy, and follow-up in-
terval. CI denotes confidence interval.
†Nonproliferative disease was the reference category.
TABLE 5. RISK OF BREAST CANCER ACCORDING TO 
HISTOLOGIC CATEGORY OF BENIGN BREAST DISEASE 
AND SIZE OF THE LARGEST RADIAL SCAR.
HISTOLOGIC CATEGORY AND 
SIZE OF RADIAL SCAR
WOMEN WITH
SUBSEQUENT
BREAST
CANCER CONTROLS
RELATIVE RISK
(95% CI)*
no. of women
Nonproliferative† 65 453 1.0
Proliferative without atypia
No radial scar
Radial scar
<4 mm
»4 mm
110
7
12
521
22
27
1.5 (1.1–2.1)
2.4 (1.0–6.0)
3.5 (1.7–7.3)
Atypical hyperplasia
No radial scar
Radial scar
<4 mm
»4 mm
48
2
11
100
8
10
3.8 (2.4–5.9)
2.0 (0.4–10.0)
8.8 (3.5–22.0)
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DISCUSSION
Prior studies have shown that women with prolif-
erative breast disease, with or without atypia, have a
significantly increased risk of breast cancer.1-7,26,27
Our results demonstrate that the presence of radial
scars almost doubles the risk of breast cancer, re-
gardless of the histologic type of benign breast dis-
ease. This risk is further increased in women with
larger or multiple radial scars.
The observation that the epithelial elements en-
trapped in the central zone of fibroelastosis in radial
scars may resemble the features of tubular carcino-
ma9,12,13,20,28-31 has led several authors to postulate
that radial scars represent an early phase in the de-
velopment of some breast cancers.8-12 The observa-
tion that hyaluronic acid levels are similar in radial
scars and tubular carcinomas32 has been cited as fur-
ther evidence in this regard. The presence of invasive
or in situ carcinoma in some radial scars13-15 has also
been cited as evidence of their malignant potential.
However, the similar features of radial scars and
some carcinomas and the coexistence of in situ or in-
vasive carcinoma within some radial scars, although
of interest, do not constitute evidence of a relation
between the two types of lesions.
Other authors have compared the frequency of ra-
dial scars in women with and those without breast
cancer. Wellings and Alpers16 postulated that radial
scars are associated with a risk of cancer on the basis
of their finding that women with breast cancer had
an increased number of radial scars. Other, similar
studies, however, have found no association between
the presence of radial scars and breast cancer.17-19
The potential relation between radial scars and
breast cancer postulated in observational reports has
until now not been validated by clinical follow-up.
The few follow-up studies that have been conducted
involved small numbers of patients and lacked suit-
able controls.20,21
As in previous studies,9,17 most of the radial scars
in our study were incidental microscopical findings,
with a median diameter of 4 mm. There was no sta-
tistically significant difference between the mean size
of the scars in the women with subsequent breast
cancer and the controls, but when the analysis was
stratified according to the histologic type of prolif-
erative disease and the size of the radial scar, the risk
of breast cancer was greater among the women with
larger scars.
Similarly, when the analysis was stratified accord-
ing to the histologic category of proliferative disease
and the number of radial scars, the risk of breast
cancer was greater among the women with a larger
number of scars. However, because of the small
numbers of women in certain strata, the confidence
intervals were wide. In a study in which extensive
sampling of the whole breast was performed, the
number of radial scars was greater in the women
with breast cancer than in those without breast can-
cer, and this finding was cited as evidence that radial
scars are premalignant lesions.16 In our study, in
contrast, the number of radial scars in excisional-
biopsy specimens did not differ significantly between
the women with subsequent breast cancer and the
controls.
Several investigators have reported bilateral and
multicentric radial scars,17-19 with frequencies as high
as 43 and 67 percent, respectively.18 Since our histo-
logic specimens were obtained by excisional biopsy,
not mastectomy, multicentricity could not be ade-
quately addressed. In an autopsy study of women
who had undergone mastectomy for carcinoma,
Nielsen et al.19 did not find an increased frequency
of radial scars in the contralateral breast. Although
in our study only limited data were available for an
analysis of the laterality of breast cancer in relation
to radial scars, we found no significant relation be-
tween the presence of radial scars and the subse-
quent development of cancer in the contralateral
breast or the ipsilateral breast. Therefore, radial scars
are probably best considered markers of an overall
increase in the risk of breast cancer. 
We can only speculate about why radial scars are
associated with an increased risk of breast cancer. Al-
though the pathogenesis of radial scars in the breast
is uncertain, a disturbance in the normal reciprocal
interaction between stromal and epithelial cells may
be involved. This disturbance, in turn, may reflect a
more general perturbation in the interaction between
stromal and epithelial cells in the breast, a phenom-
enon that has been postulated to be important in
the pathogenesis of breast cancer.33
Our findings have implications for pathologists
who examine breast-biopsy specimens and for clini-
cians. The data suggest that pathologists should spe-
cifically report the presence of radial scars in benign
breast lesions and should note the size of the largest
radial scar and the number of such lesions. Patients
in whom a breast biopsy reveals one or more radial
scars should undergo the same regular clinical and
mammographic follow-up recommended for other
patients with benign breast lesions associated with a
moderately increased risk of breast cancer in either
breast. The radial scars evaluated in our study were
primarily small, incidentally detected lesions. Wheth-
er or not our results can be extrapolated to radial
scars large enough to be detected by mammography
is an unresolved issue that merits further investiga-
tion, particularly in view of the apparent association
between larger radial scars and a higher risk of breast
cancer in our study population.
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